Park Medi World to expand hospital network across north India, add 1,450 beds by FY28

Park Medi World plans to add 1,450 beds by FY28, expanding its northern India network. The hospital chain focuses on Tier 1, 2, and 3 cities for efficient scaling. Acquisitions will target hospitals with 200-250 beds, expandable to 350. The company reported record net profit and revenue in FY26. Park Medi World is also adopting cleaner energy systems across its facilities.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/M7wtTK1
via IFTTT

Read More

Amrutanjan Health plans to set up 1 lakh direct chemist outlets in FY27

Amrutanjan Health Care plans to establish one lakh direct chemist outlets this fiscal year. The company achieved strong growth in pain management and women's hygiene categories during FY26. This expansion aims to increase brand availability beyond its traditional strongholds in the south and east. Amrutanjan also intends to relaunch its congestion-relief brand, Relief, in the current year. The company remains confident about demand in FY27, supported by its product portfolio.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/iVRtT8w
via IFTTT

Read More

Is longevity the new flex? Why the new wellness status game is all about health data

Wellness has shifted from luxury retreats to daily personal management and longevity. Wearable technology now tracks health markers, encouraging consistent self-care habits. Fitness goals are increasingly performance-driven, moving beyond aesthetics and appearance. Nervous system regulation through breathwork and sound baths is gaining prominence. This new focus emphasizes consistent, unglamorous daily habits for long-term health.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/DMfNSWG
via IFTTT

Read More

Cipla Pharma license cancellation: FDA withdraws order after HC raps it for going 'overboard'

Maharashtra FDA withdrew its order to cancel Cipla Pharma's drug sale license after court intervention. The Bombay High Court criticized the regulator for acting in a high-handed and overboard manner. The FDA will now issue a fresh show cause notice to the company for a reasoned order. This action followed alleged irregularities in packaging, storage, and recall of specific tablets.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/8RsXVBK
via IFTTT

Read More

Drugmakers may bear sole responsibility for overpricing essential medicines under NPPA proposal

The National Pharmaceutical Pricing Authority aims to hold drug manufacturers solely accountable for the excessive pricing of essential medications. This initiative could shield retail chemists and hospitals from legal repercussions concerning pricing infractions. Manufacturers are likely to challenge the proposal, alleging it is uncompromising and unjust. Previously, substantial penalties have been levied against drugmakers for such transgressions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Jwgi9SV
via IFTTT

Read More

Jubilant Generics receives show-cause notice demanding over Rs 105 cr

Jubilant Generics received a Rs 105.5 crore GST show-cause notice from Uttarakhand authorities. The notice alleges improper availment of tax refund and Advance Authorisation Scheme benefits. This action pertains to the fiscal years 2020-21 and 2021-22. The company plans to contest the notice and file a detailed reply soon. Jubilant Pharmova expects no significant financial or operational impact.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/m9k6XZl
via IFTTT

Read More

Yatharth Hospitals draws interest from Aster, Advent as healthcare consolidation heats up

Aster DM Quality Care is negotiating to acquire a controlling stake in Yatharth Hospitals. This potential acquisition aims to consolidate the hospital sector amid private equity interest. Yatharth Hospitals' stock has seen a significant rise in anticipation of a potential trade. The deal would trigger an open offer for additional shares, expanding the acquirer's ownership. This move would significantly strengthen Aster DM Quality Care's presence in northern India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Kn6AYql
via IFTTT

Read More